ARTICLE | Company News
Sunshine Biopharma, Jewish General Hospital deal
June 27, 2011 7:00 AM UTC
The biotech and hospital partnered to conduct preclinical and Phase I testing of Sunshine's Adva-27a to treat cancer. Adva-27a is a small molecule topoisomerase II (TOP2) inhibitor. Details were not...